24-Jun-2026 08:58:37
SHILPAMEDExpansion
SHILPA MEDICARE LIMITED : ANNOUNCES COMMISSIONING OF ADC GMP MANUFACTURING FACILITY
• Shilpa Biologicals Ltd, a subsidiary, commissioned a state-of-the-art Antibody-Drug Conjugate (ADC) GMP Manufacturing Facility in Dharwad. • The facility is purpose-built to meet global regulatory approval standards including US FDA and EMA. • This marks an evolution of Shilpa Medicare's expertise in highly potent compound manufacturing. • The facility offers integrated, end-to-end ADC Drug Substance development and manufacturing capabilities. • Shilpa aims to become a globally relevant CDMO partner for advanced oncology ADC Drug Substance manufacturing. Impact: Strategic expansion into integrated ADC manufacturing
Shilpa Medicare Limited
Open attachment